Cingulate CINGW
NASDAQ CINGW
$0.01 +0.00 (+4.29%)
As of: Sep 9, 2026 · 11:16 AM EDT

Cingulate (CINGW) Cash & Equivalents (2021 - 2026)

Cingulate's (CINGW) quarterly Cash & Equivalents came in at $28.4 million in Q2 2026, up 159.31% quarter-over-quarter from $11.0 million in Q4 2025.

Analysis

Cingulate (CINGW) Cash & Equivalents (2021 - 2026) Analysis & Trends

Cingulate (CINGW) has reported Cash & Equivalents for 6 consecutive years, with $28.4 million the latest figure, recorded in Q2 2026.

  • For the quarter ending Q2 2026, Cash & Equivalents changed N/A year-over-year to $28.4 million; the trailing twelve-month figure through Jun 2026 stood at $28.4 million (changed N/A YoY), and the FY2025 full-year result was $11.0 million, down 10.3% from the prior year.
  • Cash & Equivalents advanced to $28.4 million in Q2 2026 per CINGW's latest filing, from $11.0 million in the prior quarter.
  • Across five years, Cash & Equivalents topped out at $28.4 million in Q2 2026 and bottomed at $52416.0 in Q4 2023.
  • Historically, Cash & Equivalents has averaged $7.4 million across 5 years, with a median of $7.2 million in 2022.
  • The sharpest annual moves came in 2023 and 2024: Cash & Equivalents tumbled 99.02% in 2023, then jumped 23196.93% in 2024.
  • Over 5 years, Cash & Equivalents stood at $5.4 million in 2022, then sank by 99.02% to $52416.0 in 2023, then surged by 23196.93% to $12.2 million in 2024, then dropped by 10.3% to $11.0 million in 2025, then surged by 159.31% to $28.4 million in 2026.
  • According to Business Quant data, Cash & Equivalents over the past three periods registered $28.4 million, $11.0 million, and $6.1 million for Q2 2026, Q4 2025, and Q3 2025 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash & Equiv. (Qtr)
1 Johnson & Johnson 646.10 Bn 625.34 Bn 17.26 Bn 20.42 Bn
2 AbbVie 441.68 Bn 435.11 Bn 12.70 Bn 6.57 Bn
3 Merck 366.62 Bn 359.48 Bn 12.21 Bn 6.85 Bn
4 Novartis Ag 266.55 Bn 258.86 Bn 11.24 Bn 7.62 Bn
5 Pfizer 159.14 Bn 147.45 Bn 10.94 Bn 976.00 Mn
6 Sanofi 52.40 Bn 45.02 Bn 10.79 Bn 7.38 Bn
7 Revolution Medicines 44.07 Bn 44.07 Bn - 815.44 Mn
8 Incyte 25.59 Bn 21.05 Bn 1.57 Bn 3.98 Bn
9 United Therapeutics 21.54 Bn 18.88 Bn 683.80 Mn 1.80 Bn
10 Cingulate 100,214.03 100,214.03 - 28.40 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 28.40 Mn
Dec 31, 2025 10.95 Mn
Sep 30, 2025 6.12 Mn
Mar 31, 2025 9.52 Mn
Dec 31, 2024 12.21 Mn
Sep 30, 2024 10.04 Mn
Jun 30, 2024 400,000.00
Mar 31, 2024 1.11 Mn
Dec 31, 2023 52,416.00
Sep 30, 2023 1.99 Mn
Jun 30, 2023 349,831.00
Mar 31, 2023 1.74 Mn
Dec 31, 2022 5.36 Mn
Sep 30, 2022 9.80 Mn
Jun 30, 2022 8.20 Mn
Mar 31, 2022 12.61 Mn
Dec 31, 2021 16.49 Mn